Strange Bedfellows: Amgen, J&J Work Together In Advance Of EPO Meeting

Amgen is working with Johnson & Johnson to ensure that a consistent message regarding the safety profile of erythropoiesis-stimulating agents is presented to FDA's Oncologic Drugs Advisory Committee